Abstract Details

Title BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 052

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Erik Wallstroem, MD, PhD (Sanofi)	Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.
Jessica Chorostecki-Vigrass	No disclosure on file
	No disclosure on file
AmirHussein Abdolalizadeh (Mohammad Ali Sahraian)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��